Nanosphere Health SciencesFRA:2CG Market Cap is €0.13 Mil as of Jul. 05, 2026. Among 1,422 Biotechnology companies, Nanosphere Health Sciences ranks worse than 99.72% on this metric.
Nanosphere Health Sciences's quarterly market cap
stayed the same
from Jun. 2025 (€0.01 Mil) to Sep. 2025 (€0.01 Mil) and
stayed the same
from Sep. 2025 (€0.01 Mil) to Dec. 2025 (€0.01 Mil).
Nanosphere Health Sciences's annual market cap
increased
from Dec. 2023 (€0.02 Mil) to Dec. 2024 (€0.10 Mil) but then
declined
from Dec. 2024 (€0.10 Mil) to Dec. 2025 (€0.01 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Nanosphere Health Sciences's Enterprise Value for Today is €0.18 Mil.
Nanosphere Health Sciences (FRA:2CG) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Nanosphere Health Sciences Market Cap Related Terms
Nanosphere Health Sciences Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:2CG vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, Nanosphere Health Sciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nanosphere Health Sciences Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nanosphere Health Sciences's Market Cap distribution charts can be found below:
* The bar in red indicates where Nanosphere Health Sciences's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nanosphere Health Sciences (FRA:2CG) has a Market Cap of €0.13 Mil as of Jul. 05, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nanosphere Health Sciences and its competitors. According to the industry distribution chart, Nanosphere Health Sciences ranks #1418 out of 1422 companies in the Biotechnology industry, placing it in the top 99.7%.
Is Nanosphere Health Sciences' Market Cap too high?
Nanosphere Health Sciences' current Market Cap is €0.13 Mil. Based on the distribution chart, Nanosphere Health Sciences ranks #1418 out of 1422 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Nanosphere Health Sciences' Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Nanosphere Health Sciences ranks #1418 out of 1422 companies for Market Cap. This places Nanosphere Health Sciences in the lower half of its industry. The industry median Market Cap is 121.26. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 121.26, based on 1,422 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nanosphere Health Sciences and its competitors. For the Biotechnology industry, the median Market Cap is 121.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nanosphere Health Sciences's current Market Cap is €0.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanosphere Health Sciences stock overvalued right now?
Nanosphere Health Sciences (FRA:2CG) has a current Market Cap of €0.13 Mil. The current Market Cap is €0.13 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Nanosphere Health Sciences (FRA:2CG), the current Market Cap is €0.13 Mil as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nanosphere Health Sciences Inc is a biotechnology company focused on providing next generation delivery of biologically active compounds through licensing and joint venture arrangements. The Company has developed and is commercializing its patented NanoSphere Delivery System, a nanotechnology platform for the delivery of biological agents such as cannabinoids, supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries. The NanoSphere Delivery System provides improved bioavailability, efficacy, and onset of effect over traditional delivery systems.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2CG has been successfully added to your 